l General Information |
Product Name | Baicalin |
General description | Baicalin is a known prolyl endopeptidase inhibitor and affects the GABA receptors. |
Synonym | (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; Baicalein 7-O-glucuronide; 7-D-Glucuronic acid-5,6-dihydroxyflavone |
Assay | ≥95%(HPLC) | CAS Number | 21967-41-9 |
Formula | C21H18O11 | Molecular Weight | 446.364 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Pale yellow or yellow solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Baicalin is a known prolyl endopeptidase inhibitor and affects the GABA receptors. |
Application | 1. Anti-Asthmatic Agents 2. Anti-Infective Agents 3. Anti-Inflammatory Agents, Non-Steroidal 4. Enzyme Inhibitors |
l Packaging & Storage |
Packaging | 25mg; 100mg; 500mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
